Jessica Bordelon, APRN
Nurse Practitioner · Hammond, LANPI 1043585854
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (35.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Rigel Pharmaceuticals, Inc. accounts for 81.2% of it on its own, with 59 other manufacturers making up the rest. Reporting peaked in 2022 at $23,222 and has fallen 88.7% since, to $2,622 in 2025. Among nurse practitioner clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 702 payments — averaging $110.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rigel Pharmaceuticals, Inc.$63K
- Dova Pharmaceuticals$2K
- EMD Serono, Inc.$1K
- Novartis$1K
- Johnson & Johnson$790
- AstraZeneca$721
- plus $9K from 54 others
What the payments were for
- Consulting fees$27,17335%
- Speaking & faculty fees$22,03428%
- Travel & lodging$14,23718%
- Food & beverage$13,81318%
- Education$3880%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$77,645 in reported general payments places this provider in the 95th percentile of 969 nurse practitioner providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 46 | $512 |
| Ondansetron OdtOndansetron | 19 | $219 |
| Ondansetron Hcl | 21 | $164 |
| Duloxetine Hcl | 13 | $59 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Hammond
- Amanda EstapaHammond$21K
- Karen DeshotelLafayette$264K
- Christopher ManuelKaplan$145K
- Tammy BennettShreveport$99K
- Matt LandryLafayette$50K
- Cynthia CobbLafayette$48K
- Ellen GentileWest Monroe$31K
- Reghan LittlepageAlexandria$24K
- April WoodrowOpelousas$24K
- Lacey VasilakisLake Charles$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.